Opinion|Videos|September 4, 2024

Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty

The panel examines the efficacy and safety profiles of gonadotropin-releasing hormone analogue (GnRHa) treatments in managing Central Precocious Puberty.

Video content above is prompted by the following:

  • What are long-term efficacy and safety data associated with gonadotropin releasing hormone analogue (GnRHa) treatment?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.


Latest CME